MedPath

D-Glutamine

Generic Name
D-Glutamine
Brand Names
Endari
Drug Type
Small Molecule
Chemical Formula
C5H10N2O3
CAS Number
5959-95-5
Unique Ingredient Identifier
63HB36CA2Y

Overview

A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells.

Indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance. Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older .

Associated Conditions

  • Osteoporosis
  • Acute Complications of Sickle Cell Disease

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Emmaus Medical, Inc.
42457-420
ORAL
5 g in 1 1
10/27/2020

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Glutamine Capsules
国药准字H20041449
化学药品
胶囊剂
5/26/2020
Glutamine Capsules
国药准字H20010192
化学药品
胶囊剂
5/22/2020
Glutamine Granules
国药准字H20020054
化学药品
颗粒剂
8/17/2020
Glutamine Granules
国药准字H20040245
化学药品
颗粒剂
5/12/2020
Glutamine Powders
国药准字H20080324
化学药品
散剂
12/20/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath